English
SpanishTrusted Resources: People & Places
Healthcare providers, researchers, and advocates
Stanford Healthcare – Spinal Muscular Atrophy
213 Quarry RoadPalo Alto, California, United States
Phone Web
Stanford Neuromuscular Program has extensive experience in diagnosing and treating spinal muscular atrophy (SMA). We are at the forefront of developing and validating new treatment approaches, such as Spinraza, the only treatment available for spinal muscular atrophy.
This disease-modifying drug halts the progression of spinal muscular atrophy and may help people regain some of the motor function they have lost. Our research team treated the first infant ever to receive Spinraza in 2013. After the FDA approved Spinraza in 2016, we treated the very first adult living with spinal muscular atrophy.
We offer specialized, comprehensive care for those living with spinal muscular atrophy at our multidisciplinary Neuromuscular Clinic Program.
BookmarkRelated Content
-
Why Texas Added Spinal Muscular Atrophy to Required Screenings for NewbornsKERA’s Sam Baker talks with Dr. Angela...
-
UW Health – Spinal Muscular AtrophyOur UW Health Kids experts are national ...
-
A ‘Miracle’: Spinraza Gives Boy, Now 5, a Chance to Grow UpIt’s now been more than four years sin...
-
Spinal Muscular Atrophy 2020: SMA Medications for Treatment Updateshttps://www.youtube.com/watch?v=dnSXnvrO...
-
Assessment of Cerebral Spinal Fluid Biomarkers and microRNA-Mediated Disease Mechanisms in Spinal Muscular Atrophy P...Cerebral spinal fluid (CSF) is a promisi...
-
Quality of Life Assessment in Adult Spinal Muscular Atrophy Patients Treated With NusinersenObjective: To retrospectively evaluate q...
-
Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and AdolescentsCentral nervous system (CNS) involvement...
